+7,105.0%
TRV vs GSK
+1,742.6%
+5,362.5%
-55.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +0.5% | -0.5% | -0.2% |
| 7D | +2.0% | +1.1% | +0.9% | +1.6% |
| 30D | +6.7% | +6.3% | +0.4% | +4.6% |
| 3M | +9.4% | +1.8% | +7.5% | +8.5% |
| 6M | +37.7% | +1.7% | +36.1% | +36.4% |
| YTD | +40.6% | +6.5% | +34.0% | +36.6% |
| 1Y | +42.4% | +9.5% | +32.9% | +37.1% |
| 3Y | +148.1% | +65.3% | +82.8% | +104.6% |
| 5Y | +181.7% | +43.7% | +138.0% | +139.8% |
| 10Y | +352.6% | +104.1% | +248.5% | +242.3% |
| All | +7,105.0% | +1,742.6% | +5,362.5% | +3,253.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling